Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras. Read more about Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras.
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation. Read more about Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Read more about Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
IL10 receptor is a novel therapeutic target in DLBCLs. Read more about IL10 receptor is a novel therapeutic target in DLBCLs.
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Read more about You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia.
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Read more about DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Read more about STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Read more about Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children.
STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Read more about STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
